Skip to main content
Premium Trial:

Request an Annual Quote

Predictive Biosciences Acquires OncoDiagnostic Laboratory

NEW YORK (GenomeWeb News) – Predictive Biosciences said today that it has acquired Cleveland, Ohio-based OncoDiagnostic Laboratory for an undisclosed sum.

OncoDiagnostic Laboratory is a Clinical Laboratory Improvement Act-certified anatomic pathology and molecular diagnostics lab serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians nationwide.

Predictive, based in Lexington, Mass., said that the acquisition provides it with a fully integrated pathology laboratory through which it will commercialize its proprietary non-invasive molecular cancer diagnostic assays. The first of these assays is a urine-biomarker based test for the detection of bladder cancer, which Predictive plans to make commercially available sometime this year.

"ODL’s subspecialty expertise and national access to hundreds of urology practices including some of the largest group practices in the US, such as the Conrad|Pearson Clinic in Tennessee and the Arizona Urology Specialists, favorably position Predictive for launching our bladder cancer test as well as future diagnostic products," Predictive President and CEO Peter Klemm said in a statement.

ODL currently employs some 40 people, including a national sales force, and will continue to operate from its Cleveland headquarters, Predictive said.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.